Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

by Global Biodefense Staff November 18, 2020, 3:18 pm
DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

by Global Biodefense Staff October 31, 2020, 2:40 pm
Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

by Global Biodefense Staff October 27, 2020, 4:40 pm
State Department: Reducing Revisionist State Biological and Chemical Weapons Threats

by Global Biodefense Staff October 27, 2020, 2:54 pm
BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

by Global Biodefense Staff October 20, 2020, 1:40 pm
NIH Funds a $9.3M Center for Precision Animal Modeling at UAB

by Global Biodefense Staff October 9, 2020, 12:09 pm
Renowned Tick Immunobiologist to Develop Lyme Disease Vaccine Under New $3.5M Federal Grant

by Global Biodefense Staff October 7, 2020, 9:48 am
Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development

by Global Biodefense Staff September 28, 2020, 10:13 am
Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection

by Global Biodefense Staff September 28, 2020, 9:36 am
Establishing a Regional Disaster Health Response System in the U.S.

by Global Biodefense Staff September 7, 2020, 2:12 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
Scent of a Virus: NIH Seeks Novel Tech to Detect COVID-19 From Skin Odors

by Global Biodefense Staff September 7, 2020, 12:17 pm
USAMMDA to Manage Tier 1 Acquisition Program for Three COVID-19 Countermeasures

by Global Biodefense Staff September 2, 2020, 2:12 pm
Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19

by Global Biodefense Staff August 6, 2020, 1:18 pm
DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

by Global Biodefense Staff July 8, 2020, 2:06 pm

Congratulations. You've reached the end of the internet.

Funding News

Contract and grant opportunities and investments to aid in meeting the challenges of public health emergencies.

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

State Department: Reducing Revisionist State Biological and Chemical Weapons Threats

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

NIH Funds a $9.3M Center for Precision Animal Modeling at UAB

Renowned Tick Immunobiologist to Develop Lyme Disease Vaccine Under New $3.5M Federal Grant

Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development

Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection

Establishing a Regional Disaster Health Response System in the U.S.

Scent of a Virus: NIH Seeks Novel Tech to Detect COVID-19 From Skin Odors

USAMMDA to Manage Tier 1 Acquisition Program for Three COVID-19 Countermeasures

Urgent Phase I/II Clinical Trial Funding to Repurpose Existing Therapeutics to Treat COVID-19

DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest Articles

More Funding News